When it is just in the first phases of commercialisation and is involved in a large R&D program there is nothing wrong with this kind of result.
I am wondering when we get to see a 1,000% annual increase in revenue - i.e. The base is too low / timing is too early to make meaningful percentage comparisons. Ideally we need to see a 10,000% increase in revenue over the next 5 years.
- Forums
- ASX - By Stock
- News: Pharmaxis reports 13% loss
When it is just in the first phases of commercialisation and is...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.76M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 99162 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 0.040 |
1 | 99807 | 0.039 |
2 | 500000 | 0.038 |
1 | 5000 | 0.037 |
2 | 295193 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 99162 | 1 |
0.041 | 14300 | 1 |
0.043 | 5769 | 1 |
0.045 | 133423 | 2 |
0.046 | 94076 | 3 |
Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
Day chart unavailable